1. Hay JE, Czaja AJ, Rakela J, Ludwig J: The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Hepatology 9: 193-197, 1989.

2. Levin DM, Baker AL, Riddell RH, et al: Nonalcoholic liver disease. Overlooked causes of liver injury in patients with heavy alcohol consumption. Am J Med 66: 429-434, 1979.

3. Theodossi A, Skene AM, Portmann B, et al: Observer variation in assessment of liver biopsies including analysis by kappa statistics. Gastroenterology 79: 232-241, 1980.

4. Van Ness MM, Diehl AM: Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? Ann Intern Med 111: 473-478, 1989.

5. Baptista A, Bianchi L, de Groote J, et al: Histopathology of the intrahepatic biliary tree. Liver 3: 161-175, 1983.

6. Bassett ML, Halliday JW, Powell LW: Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 6: 24-29, 1986.

7. Brouwer A, Wisse E, Knook DL: Sinusoidal endothelial cells and perisinusoidal fat-storing cells. In Arias IM, Jakoby WB, Popper H (eds): The Liver: Biology and Pathobiology, 2nd ed. New York, 1988, Raven Press. pp 665-682.

8. Fallon HJ: Alcohol and the terminal hepatic venule: Early lesion or late residual? Gastroenterology 83: 930-932, 1982.

9. Ger R: Surgical anatomy of the liver. Surg Clin No Amer 69: 179-192, 1989.

10. Gerber MA, Thung SN: Hepatic oncocytes. Incidence, staining characteristics, and ultrastructural features. Am J Clin Pathol 75: 498-503, 1981.

11. Gerber MA, Thung SN: Histology of the liver. Am J Surg Pathol 11: 709-722, 1987.

12. Gumucio JJ, Miller DL: Functional implications of liver cell heterogeneity. Gastroenterology 80: 393-403, 1981.

13. Gupta SC, Gupta CD, Arora AK: Subsegmentation of the human liver. J Anat 124: 413-423, 1977.

14. Harman D: Lupofuscin and ceroid formation: The cellular recycling system. Adv Exp Med and Biol 266: 3-15, 1989.

15. Horn T, Lyon H, Christoffersen P: The blood hepatocytic barrier: a light microscopical, transmission- and scanning electron microscopic study. Liver 6: 233-245, 1986.

16. Iwatsuki S, Sheahan DG, Starzl TE: The changing face of hepatic resection. Curr Probl Surg 26: 281-379, 1989.

17. Jones EA, Summerfield JA: Kupffer cells. In Arias IM, Jakoby WB, Popper H (eds): The Liver: Biology and Pathobiology, 2nd ed. New York, 1988, Raven Press. pp 683-704.

18. Jungermann K: Metabolic zonation of liver parenchyma. Semin Liver Dis 8: 329-341, 1988.

19. Koelma IA, Nap M, Huitema S, et al: Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters. Arch Pathol Lab Med 110: 1035-1040, 1986.

20. Lefkowitch JH, Arborgh BÅM, Scheuer PJ: Oxyphilic granular hepatocytes. Mitochondrion-rich liver cells in hepatic diseases. Am J Clin Pathol 74: 432-441, 1980.

21. Ludwig J: New concepts in biliary cirrhosis. Semin Liver Dis 7: 293-301, 1987.

22. Mukai JK, Stack CM, Turner DA, et al: Imaging of surgically relevant hepatic vascular and segmental anatomy. Part I. Normal anatomy. AJR 149: 287-292, 1987.

23. Nasrallah SM, Nassar VH, Galambos JT: Importance of terminal hepatic venule thickening. Arch Pathol Lab Med 104: 84-86, 1980.

24. Petrelli M, Scheuer PJ: Variation in subcapsular liver structure and its significance in the interpretation of wedge biopsies. J Clin Pathol 20: 743-748, 1967.

25. Rappaport AM: The microcirculatory acinar concept of normal and pathological hepatic structure. Beitr Pathol 157: 215-243, 1976.

26. Rappaport AM: Physioanatomic considerations. In Schiff L, Schiff ER (eds): Disease of the Liver, 6th ed. Philadelphia, 1987, JB Lippincott. pp 1-46.

27. Tsukamoto H, Gaal K, French SW: Insights into the pathogenesis of alcoholic liver necrosis and fibrosis: Status report. Hepatology 12: 599-608, 1990.

28. Watanabe T, Tanaka Y: Age-related alterations in the size of human hepatocytes: a study of mononuclear and binucleate cells. Virchows Arch [B] 39: 9-20, 1982.

29. Zajicek G, Oren R, Weinreb M Jr: The streaming liver. Liver 5: 293-300, 1985.

30. Abdi W, Millan JC, Mezey E: Sampling variability on percutaneous liver biopsy. Arch Intern Med 139: 667-669, 1979.

31. Babb RR, Jackman RJ: Needle biopsy of the liver. A critique of four currently available methods. West J Med 150: 39-42, 1989.

32. Barry M: Liver iron concentration, stainable iron, and total body storage iron. Gut 15: 411-415, 1974.

33. Brissot P, Bourel M, Herry D, et al: Assessment of liver iron content in 271 patients: A reevaluation of direct and indirect methods. Gastroenterology 80: 557-565, 1981.

34. Brumm C, Schulze C, Charels K, et al: The signficance of alpha-fetoprotein and other tumor markers in differential immunocytochemistry of primary liver tumors. Histopathology 14: 503-513, 1989.

35. Christensen WN, Boitnott JK, Kuhajda FP: Immunoperoxidase staining as a diagnostic aid for hepatocellular carcinoma. Mod Pathol 2: 8-12, 1989.

36. Colombo M, Del Ninno E, de Franchis R, et al: Ultrasound-assisted percutaneous liver biopsy: Superiority of the Tru-Cut over the Menghini needle for diagnosis of cirrhosis. Gastroenterology 95: 487-489, 1988.

37. Demetris AJ, Jaffe R, Starzl TE: A review of adult and pediatric post-transplant liver pathology. Pathol Annu 22 (pt 2): 347-386, 1987.

38. Ganjei P, Nadja M, Albores-Saavedra J, Morales AR: Histologic markers in primary and metastatic tumors of the liver. Cancer 62: 1994-1998, 1988.

39. Gerber MA, Thung SN: The diagnostic value of immunohistochemical demonstration of hepatitis viral antigens in the liver. Hum Pathol 18: 771-774, 1987.

40. Glenthøj A, Sehested M, Torp-Pedersen S: Diagnostic reliability of histological and cytological fine needle biopsies from focal liver lesions. Histopathology 15: 375-383, 1989.

41. Goldfischer S, Popper H, Sternlieb I: The signifcance of variations in the distribution of copper in liver disease. Am J Pathol 99: 715-730, 1980.

42. Guarascio P, Yentis F, Cevikbas U, et al: Value of copper-associated protein in diagnostic assessment of liver biopsy. J Clin Pathol 36: 18-23, 1983.

43. Hajdu SI, D'Ambrosio FG, Fields V, Lightdale CJ: Aspiration and brush cytology of the liver. Semin Diag Pathol 3: 227-238, 1986.

44. Hølund B, Poulsen H, Schlichting P: Reproducibility of liver biopsy diagnosis in relation to the size of the specimen. Scand J Gastroenterol 15: 329-335, 1980.

45. Irons RD, Schenk EA, Lee JCK: Cytochemical methods for copper. Semiquantitative screening procedure for identification of abnormal copper levels in liver. Arch Pathol Lab Med 101: 298-301, 1977.

46. Jacques SM, Qureshi F: Herpes simplex virus hepatitis in pregnancy: A clinicopathological study of three cases. Hum Pathol 23: 183-187, 1992.

47. Jain S, Scheuer PJ, Archer B, et al: Histological demonstration of copper and copper-associated protein in chronic liver disease. J Clin Pathol 31: 784-790, 1978.

48. Johnson DE, Herndie BG, Medeiros LJ, et al: The diagnostic utility of the keratin profiles of hepatocellular carcinoma and cholangiocarcinoma. Am J Surg Pathol 12: 187-197, 1988.

49. Maharaj B, Maharaj RJ, Leary WP, et al: Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1: 523-525, 1986.

50. McAfee JH, Keeffe EB, Lee RG, Rösch J: Transjugular liver biopsy. Hepatology 15: 726-732, 1992.

51. Palmer PE, Wolfe HJ, Dayal Y, Gang DL: Immunocytochemical diagnosis of alpha-1-antrypsin deficiency. Am J Surg Pathol 2: 275-281, 1978.

52. Paya CV, Holley KE, Wiesner RH, et al: Early diagnosis of cytomegalovirus hepatitis in liver transplant recipients: Role of immunostaining, DNA hybridization and culture of hepatic tissue. Hepatology 12: 119-126, 1990.

53. Perry MD, Johnston WW: Needle biopsy of the liver for the diagnosis of nonneoplastic liver disease. Acta Cytol 29: 385-390, 1985.

54. Phillips MJ, Poucell S, Patterson J, Valencia P: The Liver: An Atlas and Text of Ultrastructural Pathology. New Yorkm, 1987, Raven Press.

55. Piccinino F, Sagnelli E, Pasquale G, et al: Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatology 2: 165-173, 1986.

56. Qizilbash A, Young-Pong O: Alpha₁ antitrypsin liver disease differential diagnosis of PAS-positive, diastase-resistant globules in liver cells. Am J Clin Pathol 79: 697-702, 1983.

57. Salaspuro M, Sipponen P: Demonstration of an intracellular copper-binding protein by orcein staining in long-standing cholestatic liver diseases. Gut 17: 787-790, 1976.

58. Scheuer PJ, Maggi G: Hepatic fibrosis and collapse: histologic distinction by orcein staining. Histopathology 4: 487-490, 1980.

59. Shikata T, Uzawa T, Yoshiwara N, et al: Staining methods of Australian antigen in paraffin sections: Detection of cytoplasmic inclusion bodies. Jpn J Exp Med 44: 25-36, 1974.

60. Soloway RD, Baggenstoss AH, Schoenfield LJ, Summerskill WHJ: Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy. Am J Dig Dis 16: 1082-1086, 1971.

61. Tao L-C: Liver and pancreas. In Bibbo M (ed): Comprehensive Cytopathology. Philadelphia, 1991, WB Saunders Co. pp. 822-859.

62. Thung SN, Gerber MA: The formation of elastic fibers in livers with massive hepatic necrosis. Arch Pathol Lab Med 106: 468-469, 1982.

63. Buyssens N: Ductular proliferation. Gastroenterology 49: 702-706, 1965.

64. Christoffersen P, Poulsen H, Skeie E: Focal liver cell necrosis accompanied by infiltration of granulocytes arising during operation. Acta Hepato-Splenol 17: 240-245, 1970.

65. Keller TC, Smetana HF: Artefacts in liver biopsies. Am J Clin Pathol 20: 738-741, 1950.

66. Kepes JJ, Oswald O: Tissue artefacts caused by sponge in embedding cassettes. Am J Surg Pathol 15: 810-812, 1991.

67. Leslie KO, Colby TV: Hepatic parenchymal lymphoid aggregates in Hodgkin's disease. Hum Pathol 15: 808-809, 1984.

68. McDonald GS, Courtney MG: Operation-associated neutrophils in a percutaneous liver biopsy: effect of prior transjugular procedure. Histopathology 10: 217-222, 1986.

69. Nakanuma Y, Ohta G: Immunohistochemical study on bile ductular proliferation in various hepatobiliary diseases. Liver 6: 205-211, 1986.

70. Popper H: The relation of mesenchymal cell products to hepatic epithelial systems. Prog Liver Dis 9: 27-38, 1990.

71. Schaffner F, Popper H: Nonspecific reactive hepatitis in aged and infirm people. Am J Dig Dis 4: 389-399, 1959.

72. Stosiek P, Karsten U, Kasper M: Monoclonal anti-cytokeratin antibodies reveal bile duct origin of cirrhotic ductular proliferations. Virchow Arch [A] 407: 233-235, 1985.

73. Thung SN: The development of proliferating ductular structures in liver disease. Arch Pathol Lab Med 114: 407-411, 1990.

74. Uchida T, Peters RL: The nature and origin of proliferated bile ductules in alcoholic liver disease. Am J Clin Pathol 79: 326-333, 1983.